Financial summary For the years ended 31 December 2011 2010 2009 2008 2007 million million million million million Revenue 227.7 213.6 197.4 164.9 141.6 Operating profit before exceptional items 42.7 37.0 26.6 20.1 17.8 Exceptional items 18.8 1.8 3.5 0.6 Operating profit 42.7 55.8 28.4 16.6 18.4 Profit before tax 43.0 54.0 26.2 15.0 16.4 Profit after tax 34.2 41.5 19.7 12.2 12.3 Net assets 140.5 153.0 114.1 111.3 95.1 Earnings per share: - Basic 20.8p 25.4p 12.1p 7.5p 7.6p - Diluted 20.5p 24.9p 11.9p 7.4p 7.5p - Basic before exceptional items 20.8p 17.0p 11.4p 8.0p 6.5p Dividends per share 8.0p 7.0p 5.0p 4.45p 4.45p Net assets per share 85.1p 93.5p 70.0p 68.3p 58.4p The information above refers to continuing operations exclusive of the discontinued operation, Devro GmbH, which was sold on 30 September 2011.
The information above for 2007 is also exclusive of the discontinued operation, BioFilm Limited, which was disposed of on 28 December 2007.
Operating profit for 2007 has been restated to exclude net finance income expense on pension and post-retirement health plan assets and liabilities.
